Intestinal and hepatic drug transporters: pharmacokinetic, pathophysiological, and pharmacogenetic roles
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intestinal and hepatic drug transporters: pharmacokinetic, pathophysiological, and pharmacogenetic roles
Authors
Keywords
Drug transporters, Pharmacokinetics, Polymorphisms, Drug–drug interaction
Journal
JOURNAL OF GASTROENTEROLOGY
Volume 50, Issue 5, Pages 508-519
Publisher
Springer Nature
Online
2015-03-13
DOI
10.1007/s00535-015-1061-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphisms
- (2014) A. D'Avolio et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- ABCG2 Dysfunction Increases Serum Uric Acid by Decreased Intestinal Urate Excretion
- (2014) Tappei Takada et al. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
- Multidrug resistance protein 4 (MRP4) polymorphisms impact the 6-mercaptopurine dose tolerance during maintenance therapy in Japanese childhood acute lymphoblastic leukemia
- (2014) Y Tanaka et al. PHARMACOGENOMICS JOURNAL
- The Effect of ABCG2 Genotype on the Population Pharmacokinetics of Sunitinib in Patients With Renal Cell Carcinoma
- (2014) Tomoyuki Mizuno et al. THERAPEUTIC DRUG MONITORING
- Population Pharmacokinetics/Pharmacodynamics of Erlotinib and Pharmacogenomic Analysis of Plasma and Cerebrospinal Fluid Drug Concentrations in Japanese Patients with Non-Small Cell Lung Cancer
- (2013) Masahide Fukudo et al. CLINICAL PHARMACOKINETICS
- Transporters in Drug Development and Clinical Pharmacology
- (2013) K M Giacomini et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Emerging Transporters of Clinical Importance: An Update From the International Transporter Consortium
- (2013) K M Hillgren et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- International Transporter Consortium Commentary on Clinically Important Transporter Polymorphisms
- (2013) K M Giacomini et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Hepatic and Intestinal Drug Transporters: Prediction of Pharmacokinetic Effects Caused by Drug-Drug Interactions and Genetic Polymorphisms
- (2012) Kenta Yoshida et al. Annual Review of Pharmacology and Toxicology
- Understanding the Critical Disposition Pathways of Statins to Assess Drug–Drug Interaction Risk During Drug Development: It's Not Just About OATP1B1
- (2012) R Elsby et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Impact of Genetic Variation in Breast Cancer Resistance Protein (BCRP/ABCG2) on Sunitinib Pharmacokinetics
- (2012) Tomoyuki Mizuno et al. Drug Metabolism and Pharmacokinetics
- The bile salt export pump (BSEP) in health and disease
- (2012) Ralf Kubitz et al. Clinics and Research in Hepatology and Gastroenterology
- The role and pathophysiological relevance of membrane transporter PepT1 in intestinal inflammation and inflammatory bowel disease
- (2011) Sarah A. Ingersoll et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Functional Significance of Genetic Polymorphisms in P-glycoprotein (MDR1, ABCB1) and Breast Cancer Resistance Protein (BCRP, ABCG2)
- (2011) Ichiro Ieiri Drug Metabolism and Pharmacokinetics
- The PepT1–NOD2 Signaling Pathway Aggravates Induced Colitis in Mice
- (2011) Guillaume Dalmasso et al. GASTROENTEROLOGY
- Is there evidence to claim or deny association between variants of the multidrug resistance gene (MDR1 or ABCB1) and inflammatory bowel disease?
- (2011) Elias Zintzaras INFLAMMATORY BOWEL DISEASES
- Organic Anion Transporting Polypeptide 1B1: a Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake
- (2011) M. Niemi et al. PHARMACOLOGICAL REVIEWS
- Therapeutic Drug Monitoring of Imatinib for Chronic Myeloid Leukemia Patients in the Chronic Phase
- (2011) Naoto Takahashi et al. PHARMACOLOGY
- ABCG2 421C>A polymorphism and high exposure of sunitinib in a patient with renal cell carcinoma
- (2010) T. Mizuno et al. ANNALS OF ONCOLOGY
- Hepatic Metabolism and Transporter Gene Variants Enhance Response to Rosuvastatin in Patients With Acute Myocardial Infarction
- (2010) Kristian M. Bailey et al. Circulation-Cardiovascular Genetics
- Multiple Genetic Loci Influence Serum Urate Levels and Their Relationship With Gout and Cardiovascular Disease Risk Factors
- (2010) Qiong Yang et al. Circulation-Cardiovascular Genetics
- ABCG2 Polymorphism Is Associated With the Low-Density Lipoprotein Cholesterol Response to Rosuvastatin
- (2010) B Tomlinson et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The multidrug-resistance protein 4 polymorphism is a new factor accounting for thiopurine sensitivity in Japanese patients with inflammatory bowel disease
- (2010) Hiromistu Ban et al. JOURNAL OF GASTROENTEROLOGY
- Membrane transporters in drug development
- (2010) NATURE REVIEWS DRUG DISCOVERY
- The impact ofSLCO1B1polymorphisms on the plasma concentration of lopinavir and ritonavir in HIV-infected men
- (2009) Fabiana B. Kohlrausch et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin
- (2009) J E Keskitalo et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Changes in mRNA Expression Levels of Solute Carrier Transporters in Inflammatory Bowel Disease Patients
- (2009) K. A. Wojtal et al. DRUG METABOLISM AND DISPOSITION
- Population pharmacokinetics of erlotinib and its pharmacokinetic/pharmacodynamic relationships in head and neck squamous cell carcinoma
- (2009) Fabienne Thomas et al. EUROPEAN JOURNAL OF CANCER
- Germline Genetic Variation in an Organic Anion Transporter Polypeptide Associated With Methotrexate Pharmacokinetics and Clinical Effects
- (2009) Lisa R. Treviño et al. JOURNAL OF CLINICAL ONCOLOGY
- Oral Sulfasalazine as a Clinical BCRP Probe Substrate: Pharmacokinetic Effects of Genetic Variation (C421A) and Pantoprazole Coadministration
- (2009) Kimberly K. Adkison et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Different effects of theABCG2c.421C>A SNP on the pharmacokinetics of fluvastatin, pravastatin and simvastatin
- (2009) Jenni E Keskitalo et al. PHARMACOGENOMICS
- ABCG2: A perspective
- (2008) Robert W. Robey et al. ADVANCED DRUG DELIVERY REVIEWS
- Pharmacogenetic Characterization of Sulfasalazine Disposition Based on NAT2 and ABCG2 (BCRP) Gene Polymorphisms in Humans
- (2008) Y Yamasaki et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study
- (2008) Abbas Dehghan et al. LANCET
- SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Major SNP (Q141K) Variant of Human ABC Transporter ABCG2 Undergoes Lysosomal and Proteasomal Degradations
- (2008) Tomoka Furukawa et al. PHARMACEUTICAL RESEARCH
- Breast cancer resistance protein (ABCG2) and drug disposition: intestinal expression, polymorphisms and sulfasalazine as an in vivo probe
- (2008) Bradley L. Urquhart et al. Pharmacogenetics and Genomics
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now